• 

  Zydus Cadila gets USFDA nod for generic drug

  India | December 22, 2021 14:31 IST

  The company has received tentative approval from the US Food and Drug Administration to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement.

• 

  Bihar, UP among seven states to be administered Zydus Cadila's ZyCoV-D vaccine first

  India | December 02, 2021 15:54 IST

  ZyCov-D, which is the first COVID-19 vaccine to be cleared by India's drug regulator for those aged 12 years and above, will only be administered to adults in the seven states as of now, sources said.

• 

  Zydus Cadila gets FDA's approval to market generic cancer drug in US

  World | November 20, 2021 15:54 IST

  The company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.  

• 

  Zydus Cadila's Covid vaccine to be administered only to adults as of now: Sources

  India | November 14, 2021 18:33 IST

  The health ministry has given a go ahead to initiate the preparatory work for the inclusion of the indigenously-developed, needle-free jab in the national Covid inoculation drive and it can be introduced in the programme anytime soon.

• 

  Zydus Cadila to reduce its 'needle-free' Covid vaccine price to Rs 265/dose: Sources

  India | October 31, 2021 15:01 IST

  The Ahmedabad-based pharma company earlier had proposed a price of Rs 1,900 for its three-dose regimen, a source had said.

• 

  Discussions on Zydus Cadila Covid vaccine pricing in last stage: Health Minister Mandaviya

  India | October 26, 2021 21:04 IST

  The RNA-based vaccine, meant for the age group of 12 to 18 besides adults, got the Emergency Use Authorisation from the drug regulator on August 20.

• 

  Just matter of time: Govt on introducing Zydus Cadila's 3-dose needle free vaccine

  India | October 07, 2021 18:17 IST

  Pharma company Zydus Cadila is learnt to have proposed a price of Rs 1,900 for its three-dose jab ZyCov-D that can be given to those above 12 years of age.

• 

  Zydus Cadila proposes price for 3-dose Covid vaccine ZyCov-D. Details

  India | October 03, 2021 18:25 IST

  The government had on Thursday said that the indigenously-developed, world's first DNA-based needle-free COVID-19 vaccine by Zydus Cadila will be introduced in the nationwide anti-coronavirus vaccination drive shortly.

• 

  What govt said on the pricing of Zydus Cadila's 3-dose upcoming vaccine

  India | October 01, 2021 11:47 IST

  "The call of the hour is to give the two-dose vaccination/full vaccination covering the entire adult population. The talk of booster dose is not pertinent at the moment," said ICMR DG Dr. Balram Bhargava.

• 

  Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources

  India | September 11, 2021 23:53 IST

  Zydus Cadila's coronavirus vaccine ZyCoV-D is likely to be launched in early October, according to sources.

• 

  Zydus Cadila gets USFDA nod for diabetes medication

  Business | September 06, 2021 13:24 IST

  The NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.  

Advertisement
• 

  Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD

  India | August 21, 2021 19:13 IST

  The company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.

• 

  'ZyCoV-D' vaccine 66% efficient against Covid Delta variant: Zydus Group MD

  India | August 23, 2021 15:10 IST

  Zydus Group MD Dr. Sharvil Patel has claimed that 'ZyCoV-D' vaccine holds about 66% efficacy against the Delta variant of COVID-19.

• 

  Zydus Cadila's ZyCoV-D Covid vaccine gets approval for emergency use in India

  News | August 21, 2021 8:20 IST

  The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.

• 

  Zydus Cadila's 'ZyCoV-D' vaccine approved for emergency use: Can your child get it?

  India | August 23, 2021 13:21 IST

  ZyCoV-D vaccine: Zydus Cadila's 3-dose vaccine 'ZyCoV-D' has finally got approval for emergency use by India's central drug authority. The vaccine is the world's first and India's indigenously developed DNA-based vaccine for Covid-19.

• 

  Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation

  News | August 20, 2021 21:05 IST

  The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.

• 

  Zydus Cadila's ZyCoV-D vaccine approved for emergency use; can be used on children too

  India | August 20, 2021 21:12 IST

  The Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said.

• 

  Govt panel recommends emergency use authorisation to Zydus Cadila's Covid vaccine

  India | August 20, 2021 17:52 IST

  ​An expert panel of India's central drug authority has recommended granting emergency use authorisation to Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D, sources said.

• 

  Zydus Cadila's Covid vaccine to get Govt's approval this week: Report

  India | August 09, 2021 12:37 IST

  Zydus Cadila's needle-free COVID-19 vaccine 'ZyCoV-D'  will be the sixth Covid vaccine to be available in India. 

• 

  Zydus Cadila seeks DGCI nod for its Covid-19 vaccine ZyCoV-D

  India | July 01, 2021 11:25 IST

  Zydus Cadila seeks Emergency Use Authorisation for its DNA vaccine, ZyCoV-D, for 12 years and above in India.